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Sir, We read with interest the case report of Basanth et al [1] and we agree with the authors that there is a need for increasing the awareness about the risk of mania with the use of interferon in subjects with hepatitis B. In continuation we would also like to add another case to the literature of mania induced by interferon 2α (IFN 2α) in a patient with chronic active hepatitis B, who responded to discontinuation of IFN 2α.
of mania during withdrawal of IFN 2α.
[3] In our case worsening of mania symptoms and emergence of psychotic symptoms while interferon was withdrawn provides credence to the above hypothesis. Our case highlights the need for regular monitoring for psychiatric symptoms during IFN 2α treatment.
Banerjee A, Jain G, Grover S, Singh J with acute onset quadriparesis with acute onset quadriparesis with acute onset quadriparesis with acute onset quadriparesis with acute onset quadriparesis mania was suspected and IFN 2α was stopped and over the next week his symptoms further worsened and he developed delusion of reference. After this he showed spontaneous Sir, improvement and was completely asymptomatic by another With reference to your letter, we wish to make the following week. IFN 2α was not restarted after recovery. Patient has been clarifications to the response by Iyer et al. under regular follow-up (for two years) and has been maintaining well without any psychotropic medications.
1. Rare causes like renal tubular acidosis (Type 1 and 2), metabolic acidosis, Liddle's syndrome and Bartter's The index case developed acute onset dysphoric mania with syndrome were mentioned with an aim to highlight some psychotic symptoms after three months of the initiation of causes of persistent hypokalemia in general that a physician IFN 2α therapy. His illness responded to stoppage of IFN 2α should consider. While discussing the causes pertinent to and he recovered completely within two weeks without any our patient only Cushing's syndrome and Secondary psychotropic medications. The temporal association of manic hyperaldosteronism from a high renin state have been symptoms with use of IFN 2α therapy and remission of mentioned.
[1]
symptoms without psychotropics incriminates IFN 2α as the offending agent. The score on Naranjo adverse reaction scale [2] after recovery from the episode was 6, indicating a probable association between mania and IFN 2α.
Unlike the case report by Basanth et al, [1] our case highlights the fact that subjects can develop mania in the absence of family history as reported by Carpiniello et al.
[3] The worsening of manic symptoms during the withdrawal of IFN 2α in our case is in line with the previous literature, [3] in which manic symptoms have been reported during withdrawal of IFN 2α. Abrupt withdrawal of IFN 2α may be responsible for the development and worsening of manic symptoms during withdrawal.
[3]
Previous reports have implicated hyperdopaminergic states to be responsible for development 2. As pointed out urinary chloride estimation is indeed of great value in unraveling the cause of hypokalemia and finds its application specifically in conditions like hypokalemia due to remote vomiting or remote diuretic use. We did not go ahead with these urine tests since we had a couple of other clinical clues to bank on, namely peripheral edema, diabetes, hypertension, metabolic acidosis and skin pigmentation. We completely agree with the assertion that hypomagnesemia is a cause for low serum K+ levels. Thyroid disorders and liquorice intake (usually as a food additive) are other causes that merit mention as rare causes of hypokalemia. Again we would like to state that these conditions were essentially less relevant to our case and hence omitted from the discussion to keep the article concise and interesting.
